世界の精巣腫瘍摘出術のベスト医師 — TOP 32

Menness Wellness Clinic所属、低侵襲手術および再建術を専門とする認定泌尿器科医。

• 男性の性機能健康およびアンドロロジーを専門
• 精巣手術および陰嚢再建術の専門家
• 生活の質（QOL）向上のための患者中心のケアに注力
• マヒドン大学シリラート病院にて研修

イルケル・ティナイ医師は、アナドル医療センターにて、低侵襲手術および新膀胱再建術を専門とする泌尿器腫瘍学のスペシャリストです。

• 泌尿器がん治療の専門家
• 泌尿器腫瘍学会理事
• 膀胱腫瘍研究グループ幹事
• 欧州泌尿器科学会会員

メリムスキー教授は、ソラスキー医療センターの軟部組織・骨腫瘍科を統括し、複雑な腫瘍症例を専門としています。

• 整形外科腫瘍学における_doctor_28_年以上の経験
• パリのギュスターヴ・ルシー研究所にて肉腫治療のフェローシップ研修を修了
• ESMO（欧州臨床腫瘍学会）の肉腫治療プロトコル担当ファカルティメンバー
• 腫瘍免疫学およびがん治療に関する広範な研究を発表

95%の成功率で2000件以上の肝胆道外科手術を実施 – アリオスマノグル教授はメディカルパーク・アンタルヤの臓器移植ユニットを率いています。

• 90%の成功率で1000件以上の肝移植手術を実施
• 複雑な臓器移植手術を専門とする
• アクデニズ大学肝臓・腎臓・膵臓移植ユニットの元責任者
• 肝胆道疾患の実験的治療に関する研究を発表

バラク・ローゼンツヴァイク医師は、イスラエルのシェバ医療センターで泌尿器腫瘍科を統括しています。フォーブス誌のイスラエル・ベストドクターに選出された外科医です。ローゼンツヴァイク医師は、前立腺、腎臓、膀胱、精巣の腫瘍治療を専門としています。臓器機能を温存するためのロボット支援手術および低侵襲がん手術に注力しています。

• メモリアル・スローン・ケタリングがんセンターで泌尿器腫瘍学のフェローシップを修了。
• ロボット支援根治的前立腺全摘除術および腎温存部分切除術を実施。
• テルアビブ大学の臨床上級講師であり、200本以上の科学論文を発表。
• MRIガイド下フュージョン生検を用いて、高精度な前立腺がん診断を行う。

ソラック医師は精巣がん治療を専門とし、ハジェテペ大学がん研究所でフェローシップ研修を修了しています。

• 乳がん、精巣がん、卵巣がん、肺がんの専門知識
• テキサス大学MDアンダーソンがんセンターで研修
• ヒサール・ホスピタル・インターコンチネンタル勤務

ハビエル・センテノ・フォルニエス医師は、名門メイヨー・クリニックで大腸外科の訓練を受け、Centro Médico Teknonの外科部門を率いています。

• 32 年 1993年の専門医取得以来の外科経験
• ERAS-Societyによる術後早期回復プロトコルの認定取得
• 低侵襲腹腔鏡下手術を専門とする
• 米国大腸肛門外科学会会員

ゾーリンゲンの認定学際的がんセンターの主任医師であるヴィオラ・フォックス博士は、血液学、腫瘍学、緩和ケアを専門としています。

• 化学療法、免疫療法、標的療法を専門とする
• 14 年の経験を持つ遺伝学の有資格専門家
• ドイツ腫瘍学・血液腫瘍学会の活動会員
• 革新的な治療法のための分子生物学研究に従事

准教授のタフシン・オザトリは、イスティニエ・リヴ大学病院にて乳がん、肺がん、消化器がんの治療を専門としています。

• 乳がん、肺がん、消化器がんを専門とする
• 2016年に准教授に昇進
• アンカラ腫瘍クリニックおよびその他の主要病院で勤務
• セルチュク大学医学部卒業

アレムダル医師は腫瘍内科を専門とし、アクデニズ大学での広範なトレーニングと泌尿器がんの治療経験を有しています。

• 2018年より腫瘍内科の専門医認定を取得
• 腫瘍学における_doctor_9570_年以上の臨床経験
• メディカル・パーク・アンタルヤ病院コンプレックスに勤務

ニール・クラインマン医師は、シェバ医療センターの結石・内視鏡泌尿器科ユニットを統括しています。複雑な腫瘍に対する腎温存レーザー手術のパイオニアです。フォーブス誌とResultMedにより、2025年および2026年のイスラエルのベストドクターに選出されました。クラインマン医師は、がん治療中に臓器機能を維持するための独自のデュアルレーザーシステムを使用しています。

• トーマス・ジェファーソン大学およびマクマスター大学で泌尿器科フェローシップを修了。
• 上部尿路がん（UTUC）、腎結石、前立腺がんに対する低侵襲治療の専門家。
• 非外科的化学アブレーションに関するOLYMPUS試験の研究者として従事。
• 米国内視鏡泌尿器科学会フェローであり、60以上の科学論文を発表。

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

泌尿器腫瘍学を専門とし、精巣腫瘍摘出術において10年以上の経験を持つ。ツァフラキディス医師はキプロスのGerman Oncology Centreに勤務。

• UCLH / Mid-Essexにて再建泌尿器科のフェローシップ修了
• 欧州泌尿器科学会（European Board of Urology）会員
• セント・アンドリュース大学名誉上級講師
• 泌尿器科の診断と治療に関する研究を主導

Cevper Ersoz医師は、メディポル・アジバデム地区病院にて、精巣腫瘍を含む泌尿器がんのロボット手術および腹腔鏡下手術を専門としています。

• _doctor_8928_年以上の泌尿器科経験を持ち、低侵襲手術に注力
• 泌尿器科研修の主要機関であるベズミアレム・ヴァクフ大学の准教授
• 泌尿器科に関する130以上の国内外の研究論文を発表
• 欧州泌尿器科学会およびトルコ泌尿器科学会の会員
• 米国トップクラスの泌尿器科であるミシガン大学で泌尿器科の研修を修了

複雑な症例を含む泌尿器科手術を専門とするボグダン医師は、Dievoサージェリーセンターで専門的なケアを提供しています。

• 幅広い泌尿器科処置を実施
• 伝統的な手法と低侵襲な手法の両方に精通
• セカンドオピニオンや専門的な評価を提供
• マスタークラスやワークショップを主導・参加

カテリーナ・ラニア医師は、サン・ラファエレ病院での豊富な研究および臨床経験を持ち、精巣腫瘍を含む男性泌尿生殖器疾患を専門としています。

• ミラノ大学を卒業し、アンドロロジー（男性医学）および泌尿器科を専門とする
• 膀胱腫瘍および男性生殖器疾患の診断および外科的処置を行う
• 泌尿生殖器系の病態生理学に関する150以上の科学論文の著者
• 国内外の泌尿器科学会に定期的に参加

シュリダール・P.S.医師は放射線療法の専門医であり、_doctor_3397_年_以上の経験を持ち、HCGマナヴァタがんセンターにて精密な腫瘍標的治療に注力しています。

• バナラス・ヒンドゥー大学で放射線療法の研修を修了
• 放射線療法における国家委員会認定医
• インド放射線腫瘍学会会員
• バンガロール腫瘍学グループ所属
• 神経腫瘍学および温熱腫瘍学を専門とする

パヴェウ・グロホヴィッチ医師（MD, PhD）は、約40年の経験を持つ肛門科医です。聖エリザベス病院のワルシャワ肛門科センターに勤務しています。痔、肛門瘻、肛門周囲膿瘍、肛門裂傷、便失禁、毛巣嚢胞の治療を行っています。また、大腸内視鏡検査や大腸ポリープ切除術も実施しています。

1979年から2016年まで、ポーランドで唯一の専門センターであるソレツ病院の肛門科ユニットに勤務していました。2016年からは聖エリザベス病院のワルシャワ肛門科センターに勤務しています。そこで新しい治療法の開発と導入を行い、診断、リハビリテーション、研究、教育活動を行っています。同センターはポーランド大腸肛門病クラブの本部でもあります。

学術・研究職：ポーランド科学アカデミー実験臨床医学研究所（1979–1997年）。ミュンヘン大学DAAD奨学生（1983–1984年）。オーストラリア、ニューカッスル大学ジョン・ハンター病院（1989–1996年）。同病院では移植研究ユニットのディレクターおよび主任科学官を務めました（1991–1996年）。